Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Profit After Tax (2009 - 2026)

Compugen (CGEN) posted quarterly Profit After Tax of $7.7 million for Q1 2026, up 6.8% year-over-year from $7.2 million in Q1 2025, and down 86.48% on a QoQ basis from $56.7 million in Q4 2025.

Analysis

Compugen (CGEN) Profit After Tax (2009 - 2026) Analysis & Trends

Compugen has reported Profit After Tax for 18 years, with the latest figure at $7.7 million in Q1 2026.

  • Profit After Tax for Q1 2026 came in at $7.7 million, up 6.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.8 million (up 774.38% YoY), and the FY2025 annual result was $35.3 million, up 348.35% from the prior year.
  • Profit After Tax eased to $7.7 million in Q1 2026, from $56.7 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $56.7 million in Q4 2025 and troughed at -$28.0 million in Q2 2023.
  • A 5-year average of $1.4 million and a median of -$3.1 million in 2022 frame the typical range for Profit After Tax.
  • The widest annual swing landed in 2023, when Profit After Tax tumbled 197.86%; it then jumped 1027.53% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$3.1 million in 2022, then jumped by 414.13% to $9.7 million in 2023, then slumped by 162.98% to -$6.1 million in 2024, then jumped by 1027.53% to $56.7 million in 2025, then plunged by 86.48% to $7.7 million in 2026.
  • Per Business Quant data, the three most recent Profit After Tax figures were $7.7 million in Q1 2026, $56.7 million in Q4 2025, and -$6.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 Compugen 242.44 Mn 156.82 Mn -92,000.00 -22.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.34 Mn
Mar 31, 2026 7.67 Mn
Dec 31, 2025 56.85 Mn
Sep 30, 2025 -6.98 Mn
Jun 30, 2025 -21.70 Mn
Mar 31, 2025 7.18 Mn
Dec 31, 2024 -6.12 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 -16.66 Mn
Mar 31, 2024 7.27 Mn
Dec 31, 2023 9.71 Mn
Sep 30, 2023 -9.85 Mn
Jun 30, 2023 -27.95 Mn
Mar 31, 2023 9.34 Mn
Dec 31, 2022 -3.09 Mn
Sep 30, 2022 -11.75 Mn
Jun 30, 2022 28.56 Mn
Mar 31, 2022 -9.71 Mn
Dec 31, 2021 -8.65 Mn
Sep 30, 2021 -6.16 Mn